Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-08-20

Clinical Trial Update: Botulinum Toxin and Mesotherapy on Enhancement of Facial Scarring [NA]

View source ↗

Summary

A clinical trial evaluating botulinum toxin with mesotherapy for enhancement of facial scarring has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: Hams Hamed Abdelrahman | Conditions: Facial Scars | NA | Status: COMPLETED